BACKGROUND: Human immunodeficiency virus (HIV) is a big threat to Indonesia and the rest of the world. People with HIV are more prone to opportunistic diseases like tuberculosis (TB) because HIV damages the immune system. AIM: This study aims to determine the prevalence and risk factors (age and gender) that contribute to pulmonary TB among HIV/AIDS patients admitted to Genteng Hospital Banyuwangi. METHODS: This research uses the Observational Analytical, Cross-Sectional method. We collected data from 372 new diagnosed HIV patients between 2019 and 2021. HIV diagnosis was obtained with a rapid test method. At the same time, a pulmonary TB diagnosis was obtained with Xpert MTB/RIF. RESULTS: We found that 372 individuals were HIV positive, and 63 patients among them were also positive for TB (16.93%). The majority of individuals were male (53.22%), in the age group of adults (26–45 years old) (62.1%). While HIV-TB patients were found among those in adult age group (16.13%), all patients positive with HIV-TB still susceptible to rifampicin treatment. The prevalence of TB among HIV patients did not differ significantly by gender or age. CONCLUSION: We found TB co-infection in newly diagnosed HIV patients. Individuals at risk of HIV infection should be screened early to minimize co-infection with other diseases that can aggravate their condition. As a result, the severity and death rate of HIV patients can be reduced in the long run.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.